The ACTG1 gene, associated with Autosomal Dominant Deafness Type 20 (DFNA20), plays a crucial role in the function and structure of inner ear cells, which are essential for hearing. Mutations in the ACTG1 gene can lead to hearing impairment, typically characterized by progressive, sensorineural hearing loss. This condition is inherited in an autosomal dominant pattern, meaning that a mutation in just one of the two copies of the gene in each cell is sufficient to cause the disorder.
To diagnose this specific type of genetic hearing loss, a genetic test targeting the ACTG1 gene can be conducted. DNA Labs UAE offers such a test, providing a comprehensive analysis to detect mutations in the ACTG1 gene that are responsible for Autosomal Dominant Deafness Type 20. The test is crucial for individuals with a family history of hearing loss or those experiencing symptoms of hearing impairment, as it can confirm the diagnosis, guide management and treatment decisions, and inform family planning.
The cost of the ACTG1 Gene Deafness Autosomal Dominant Type 20 Genetic Test at DNA Labs UAE is 4400 AED. The test is conducted in a state-of-the-art laboratory setting by experienced geneticists and technicians, ensuring accurate and reliable results. The process involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for the presence of mutations in the ACTG1 gene.
By opting for this genetic test, individuals and families can gain valuable insights into the genetic basis of hearing loss, enabling informed decisions regarding healthcare and lifestyle adjustments to better manage the condition.
The MYO6 Gene Deafness Autosomal Dominant Type 22 Genetic Test is a specialized diagnostic procedure available at DNA Labs UAE, designed to identify mutations in the MYO6 gene, which are associated with Autosomal Dominant Non-Syndromic Sensorineural Hearing Loss (ADNSHL) Type 22. This condition is characterized by varying degrees of hearing impairment that can present from birth or develop later in life, affecting individuals and families across generations due to its autosomal dominant inheritance pattern.
The test is crucial for families with a history of hearing loss, as it provides essential information for understanding the genetic basis of their condition. Early detection through genetic testing can facilitate timely interventions and support, including hearing aids, cochlear implants, or other therapeutic approaches tailored to the individual's needs. Additionally, it offers valuable insights for family planning and the assessment of risk in future generations.
Performed in the state-of-the-art facilities of DNA Labs UAE, the test involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific mutations in the MYO6 gene. The cost of the test is 4400 AED, reflecting the comprehensive analysis and personalized consultation provided to discuss the results and their implications for the patient and their family.
The SIX1 Gene Deafness Autosomal Dominant Type 23 Genetic Test is a specialized diagnostic procedure aimed at identifying mutations in the SIX1 gene, which are linked to Autosomal Dominant Deafness Type 23 (DFNA23). This condition is characterized by varying degrees of hearing loss, often identified in early childhood or adolescence. The SIX1 gene plays a crucial role in the development of the inner ear, and mutations in this gene can disrupt normal hearing capabilities.
Conducted at DNA Labs UAE, this genetic test is pivotal for families with a history of hearing loss, providing them with crucial information regarding the genetic underpinnings of their condition. The test involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed for specific genetic alterations associated with DFNA23.
The cost of the SIX1 Gene Deafness Autosomal Dominant Type 23 Genetic Test is 4400 AED. This price reflects the comprehensive nature of the test, including the collection of the sample, the genetic analysis, and the provision of a detailed report that explains the results. This report is instrumental for affected individuals and their families in understanding their condition and planning for any necessary medical or supportive interventions.
DNA Labs UAE, known for its state-of-the-art facilities and highly qualified staff, ensures that the test is conducted with the highest standards of accuracy and confidentiality. The results from this test can significantly impact the management and treatment of hearing loss, offering a pathway to genetic counseling and personalized care strategies for affected individuals and their families.
The SLC17A8 gene is implicated in a form of hearing loss known as Deafness Autosomal Dominant Type 25 (DFNA25). This condition is characterized by a variation in the SLC17A8 gene, which plays a critical role in the function of the inner ear, affecting the ability to hear. Genetic testing for mutations in the SLC17A8 gene is crucial for diagnosing this specific type of hereditary hearing loss, enabling individuals and families to understand their condition better and make informed decisions regarding their health and management options.
At DNA Labs UAE, a specialized genetic test is available to identify mutations in the SLC17A8 gene associated with Deafness Autosomal Dominant Type 25. The test is a comprehensive analysis designed to detect the specific genetic alterations that lead to this condition, providing a definitive diagnosis for affected individuals or those at risk.
The cost of the SLC17A8 gene deafness autosomal dominant type 25 genetic test at DNA Labs UAE is 4400 AED. This investment covers the expenses of the genetic analysis, including the collection of a DNA sample, typically through a blood draw or cheek swab, the laboratory processing, and the expert interpretation of the results. Following the test, individuals receive a detailed report that explains the findings and their implications for hearing health, with recommendations for follow-up care or interventions as needed. This genetic test is a valuable tool for those with a family history of hearing loss or early signs of hearing impairment, offering insights that can lead to early intervention and support.
The GRHL2 gene, associated with Deafness Autosomal Dominant Type 28 (DFNA28), plays a critical role in the development and maintenance of the ear's structure and function. Mutations in this gene can lead to hearing loss that is passed down through families in a pattern known as autosomal dominant inheritance. This means that only one copy of the altered gene in each cell is sufficient to cause the disorder, and it can be inherited from just one affected parent.
To diagnose this specific type of genetic hearing loss, a genetic test targeting the GRHL2 gene can be conducted. This test involves analyzing the DNA to look for mutations in the GRHL2 gene that are known to cause DFNA28. It is a crucial step for affected families to understand their genetic background, potential risks for future generations, and to explore suitable management or treatment options.
In the UAE, this specific genetic test for the GRHL2 gene can be performed at DNA Labs UAE, a reputable facility known for its comprehensive range of genetic testing services. The cost for this test is 4400 AED, which translates to approximately 1197 USD. The price reflects the sophisticated technology and expertise required to accurately identify mutations in the GRHL2 gene and provide a reliable diagnosis. Individuals considering this test should consult with a healthcare provider or a genetic counselor to discuss the implications of the results and the best course of action based on their personal and family medical history.
The "KCNQ4 Gene Deafness Autosomal Dominant Type 2A Genetic Test" is a specialized diagnostic tool designed to identify mutations in the KCNQ4 gene, which are known to cause Autosomal Dominant Non-Syndromic Hearing Loss (ADNSHL) type 2A. This form of hearing loss is characterized by its inheritance pattern, where only one copy of the mutated gene from an affected parent can lead to the condition in the offspring, showcasing a dominant inheritance pattern.
The KCNQ4 gene plays a critical role in the function of inner ear cells by contributing to the proper creation of potassium channels. These channels are essential for the conversion of sound waves into electrical signals that the brain can interpret as sound. Mutations in the KCNQ4 gene disrupt this process, leading to progressive hearing loss.
The test, offered by DNA Labs UAE, utilizes advanced genetic sequencing technologies to scrutinize the KCNQ4 gene for any abnormalities that might be responsible for hearing loss. By providing a precise genetic diagnosis, the test enables targeted management and counseling for affected individuals and their families. It is particularly beneficial for early detection, allowing for timely intervention strategies that can significantly improve the quality of life for those with the condition.
Priced at 4400 AED, this genetic test represents a crucial investment for families with a history of hearing loss, offering them valuable insights into their genetic makeup and the potential for hereditary hearing loss conditions. Conducted in the state-of-the-art facilities of DNA Labs UAE, the test adheres to high standards of accuracy, confidentiality, and ethical considerations, ensuring reliable results for patients seeking clarity about their genetic health.
The GJB3 Gene Deafness Autosomal Dominant Type 2B Genetic Test is a specialized diagnostic tool designed to identify mutations in the GJB3 gene, which have been linked to a form of hearing loss known as Autosomal Dominant Deafness Type 2B. This condition is characterized by varying degrees of hearing impairment, which can be present from birth or develop later in life. The test is crucial for individuals with a family history of hearing loss or those experiencing symptoms, as it can provide definitive genetic evidence of the condition, enabling early intervention and tailored management strategies.
Performed at DNA Labs UAE, the test involves collecting a DNA sample, typically through a blood draw or a cheek swab, which is then analyzed in the laboratory to detect any genetic abnormalities in the GJB3 gene. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in this specific gene. By opting for this test, individuals gain valuable insights into their genetic makeup, empowering them with the information needed to make informed decisions about their health and the health of their families.
The TMC1 Gene Deafness Autosomal Dominant Type 36 Genetic Test is a specialized diagnostic examination offered by DNA Labs UAE, designed to detect mutations in the TMC1 gene, which are associated with Autosomal Dominant Non-Syndromic Hearing Loss (ADNSHL) type 36. This condition is characterized by varying degrees of hearing impairment that can present from birth or develop later in life, primarily affecting the ability to perceive sound due to genetic abnormalities.
This test is crucial for individuals with a family history of hearing loss or those showing symptoms of auditory impairment, as it helps in confirming the diagnosis, understanding the risk of transmission to offspring, and aiding in the management and treatment planning of the condition. By analyzing a sample of the patient's DNA, the test identifies specific mutations in the TMC1 gene that are linked to this form of hearing loss, providing valuable genetic insights.
The cost of the TMC1 Gene Deafness Autosomal Dominant Type 36 Genetic Test at DNA Labs UAE is 4400 AED. The price reflects the comprehensive nature of the genetic analysis, the expertise required to interpret the results, and the significant impact the findings can have on the patient's treatment and lifestyle adjustments. Patients considering this test are advised to consult with a healthcare provider or a genetic counselor to understand its implications fully and how the results may influence their health management strategies.
The DSPP gene, known for its role in dental development and hearing, has been linked to a specific genetic condition known as Deafness Autosomal Dominant Type 39 with Dentinogenesis Imperfecta Type 1. This condition is characterized by hearing loss that is inherited in an autosomal dominant pattern, meaning a single copy of the altered gene in each cell is sufficient to cause the disorder. Additionally, affected individuals may experience Dentinogenesis Imperfecta Type 1, a dental disorder that leads to discolored, weak, or brittle teeth due to improper formation of dentin, the primary material beneath the tooth's enamel.
To diagnose this condition, a specific genetic test is available at DNA Labs UAE, a facility known for its comprehensive genetic testing services. The test targets mutations in the DSPP gene to confirm the diagnosis of Deafness Autosomal Dominant Type 39 with Dentinogenesis Imperfecta Type 1. The cost of this genetic test is 4400 AED, a price that reflects the intricate technologies and expert analysis required to accurately identify the genetic alteration responsible for the condition.
This test is crucial for affected individuals and their families for several reasons. Firstly, it provides a definitive diagnosis, which is essential for understanding the condition and its implications. Secondly, it can inform treatment decisions, particularly for dental issues associated with Dentinogenesis Imperfecta Type 1. Lastly, it offers valuable information for family planning, as it helps to determine the risk of passing the condition to future generations.
The "GJB2 Gene Deafness Autosomal Dominant Type 3A Genetic Test" is a specialized diagnostic tool designed to identify mutations in the GJB2 gene, which are linked to Autosomal Dominant Deafness Type 3A. This condition is characterized by varying degrees of hearing loss that is passed down through families in an autosomal dominant pattern, meaning only one copy of the altered gene is necessary for the trait to be expressed. The GJB2 gene plays a crucial role in the function of cochlear hair cells and the potassium recycling pathway in the inner ear, which are essential for normal hearing.
Conducted at DNA Labs UAE, a leading facility in genetic testing, this test is priced at 4400 AED. It involves collecting a DNA sample, usually through a blood draw or a cheek swab, which is then analyzed for specific genetic mutations associated with this form of deafness. The results can provide valuable information for affected individuals and their families, including the confirmation of a genetic diagnosis, understanding the risk of passing the condition to offspring, and guiding decisions about management and treatment options. As with any genetic test, counseling before and after the test is recommended to ensure individuals fully understand the implications of the results.
